WebAug 9, 2024 · CAMBRIDGE, Mass., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore... WebJun 8, 2024 · And on Thursday, Director Terrance McGuire bought $299,997 worth of Cyclerion Therapeutics, buying 96,153 shares at a cost of $3.12 each. Cyclerion Therapeutics is trading up about 16.7% on the day...
Cyclerion Therapeutics, Inc. (CYCN) - Yahoo Finance
WebCyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM Proxy Statement - Notice of... WebFind the latest Carnival Corporation & plc (CCL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. chinaexe
CYCN
WebThe CYCN aims to build the capacity of young people in their endeavours to address climate change and other environmental issues, and advocate on climate change from a youth perspective. The network is run by a team of dedicated volunteer professionals and young people from across the Commonwealth, with support from the Youth Division of the ... WebCyclerion Therapeutics, Inc. (CYCN) Stock Forum & Discussion - Yahoo Finance Finance Home Watchlists My Portfolio Crypto Yahoo Finance Plus Screeners Videos Personal … WebMar 17, 2024 · CYCN Stock Overview. Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) … china exchange holidays 2022